Vaxart
VXRT
#9399
Rank
โ‚ฌ73.92 M
Marketcap
0,31ย โ‚ฌ
Share price
-2.16%
Change (1 day)
-48.51%
Change (1 year)

Vaxart (VXRT) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : โ‚ฌ0.11 Billion

According to Vaxart's latest financial reports the company's total liabilities are โ‚ฌ0.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vaxart - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ0.10 B235.52%
2023-12-31โ‚ฌ30.77 M-23.66%
2022-12-31โ‚ฌ40.31 M35.75%
2021-12-31โ‚ฌ29.7 M25.21%
2020-12-31โ‚ฌ23.72 M10.36%
2019-12-31โ‚ฌ21.49 M2.51%
2018-12-31โ‚ฌ20.96 M
2017-06-30โ‚ฌ18.75 M-21.4%
2016-06-30โ‚ฌ23.86 M168.37%
2015-06-30โ‚ฌ8.89 M-55.07%
2014-06-30โ‚ฌ19.79 M44.69%
2013-06-30โ‚ฌ13.67 M
2011-12-31โ‚ฌ30.1 M-24.88%
2010-12-31โ‚ฌ40.07 M69.31%
2009-12-31โ‚ฌ23.66 M44.88%
2008-12-31โ‚ฌ16.33 M-74.08%
2007-12-31โ‚ฌ63.03 M-46.16%
2006-12-31โ‚ฌ0.11 B-17.2%
2005-12-31โ‚ฌ0.14 B128.76%
2004-12-31โ‚ฌ61.81 M14.47%
2003-12-31โ‚ฌ53.99 M28.91%
2002-12-31โ‚ฌ41.88 M-69.95%
2001-12-31โ‚ฌ0.13 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NRC Health
NRC
โ‚ฌ0.10 B-7.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
โ‚ฌ2.67 M-97.60% Bahamas